Camrelizumab Plus Stereotactic Body Radiotherapy vs Camrelizumab Alone For Oligometastatic Nasopharyngeal Carcinoma

Abroad (travel likely)RecruitingPHASE3

Conditions

Nasopharyngeal Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Contact: Study coordinator (Ming-Yuan Chen, MD, PhD) · chmingy@mail.sysu.edu.cn · 86-20-8734-3624
Contact: Principal Investigator (Ming-Yuan Chen, MD, PhD)

Study leads

Ming-Yuan Chen, MD, PhD
Study Chair
Sun Yat-Sen University Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Nivolumab in Children and Adults With Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma · Nasopharyngeal Cancer · Nasopharyngeal Neoplasms

Abroad (travel likely)RecruitingPHASE2

Aachen, Germany · Aachen, Germany

Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma · High-Risk Cancer · Maintenance Therapy

Abroad (travel likely)RecruitingPHASE3

Ganzhou, China · Guangzhou, China

Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC

Nasopharyngeal Carcinoma (NPC)

Abroad (travel likely)RecruitingPHASE3

Nanning, China

Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response

Nasopharyngeal Carcinoma

Abroad (travel likely)RecruitingPHASE3

Fuzhou, China · Xiamen, China